Y Mabs Therapeutics shares owned by Memorial Sloan Kettering Cancer Center
Quarter-by-quarter ownership of Y Mabs Therapeutics (YMAB) shares owned by Memorial Sloan Kettering Cancer Center
from 13F filings
Historical chart of Memorial Sloan Kettering Cancer Center investment in Y Mabs Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Y Mabs Therapeutics held by Memorial Sloan Kettering Cancer Center consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Y Mabs Therapeutics by Memorial Sloan Kettering Cancer Center
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-09-30 | $1.0M | 191k | 5.45 |
| 2023-06-30 | $1.3M | 191k | 6.79 |
| 2023-03-31 | $958k | 191k | 5.01 |
| 2022-12-31 | $933k | 191k | 4.88 |
| 2022-09-30 | $2.8M | 191k | 14.42 |
| 2022-06-30 | $2.9M | 191k | 15.13 |
| 2022-03-31 | $2.3M | 191k | 11.88 |
| 2021-12-31 | $3.1M | 191k | 16.21 |
| 2021-09-30 | $6.2M | 217k | 28.54 |
| 2021-06-30 | $7.3M | 217k | 33.80 |
| 2021-03-31 | $6.6M | 217k | 30.24 |
| 2020-12-31 | $11M | 217k | 49.51 |
More positions owned by Memorial Sloan Kettering Cancer Center
View all positions for Memorial Sloan Kettering Cancer Center